UBE2A Antikörper (AA 81-152) (Cy3)

Produktnummer ABIN1416587

Produktdetails anti-UBE2A Antikörper (Cy3)

Target: UBE2A (ube2a) (Ubiquitin-Conjugating Enzyme E2A (ube2a))

Bindungsspezifität: AA 81-152

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser UBE2A Antikörper ist konjugiert mit Cy3

Applikation: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Homologie: Human,Mouse,Rat,Cow,Chicken

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human UBE2A/RAD6

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu UBE2A

Target: UBE2A (ube2a) (Ubiquitin-Conjugating Enzyme E2A (ube2a))

Andere Bezeichnung: UBE2A (ube2a Produkte)

Synonyme: BHR6A antikoerper, HR6A antikoerper, hhr6a antikoerper, rad6a antikoerper, ubc2 antikoerper, mp:zf637-2-000771 antikoerper, si:bz46j2.4 antikoerper, wu:fa01h11 antikoerper, HHR6A antikoerper, MRXS30 antikoerper, MRXSN antikoerper, RAD6A antikoerper, UBC2 antikoerper, Mhr6a antikoerper, ubiquitin conjugating enzyme E2 A antikoerper, ubiquitin conjugating enzyme E2 A L homeolog antikoerper, ubiquitin-conjugating enzyme E2A (RAD6 homolog) antikoerper, ubiquitin-conjugating enzyme E2A antikoerper, UBE2A antikoerper, ube2a.L antikoerper, ube2a antikoerper, Ube2a antikoerper

Hintergrund:

Synonyms: BHR6A, hHR6A, HR6A, mHR6A, RAD6 homolog A, RAD6A, RAD6B, UBC-1, UBC2, UBC6, UBCD6, UBE2A, UBE2A_HUMAN, UBE2B, Ubiquitin carrier protein A, Ubiquitin carrier protein, Ubiquitin conjugating enzyme E2 17 kDa, Ubiquitin conjugating enzyme E2 21.5 kDa, Ubiquitin conjugating enzyme E2 A, Ubiquitin protein ligase A, Ubiquitin-conjugating enzyme E2 A, Ubiquitin-conjugating enzyme E2-17 kDa, Ubiquitin-conjugating enzyme E2-21.5 kDa, Ubiquitin-protein ligase A.

Background: The ubiquitin (Ub) pathway involves three sequential enzymatic steps that facilitate the conjugation of Ub and Ub-like molecules to specific protein substrates. The first step requires the ATP-dependent activation of the Ub C-terminus and the assembly of multi-Ub chains by the Ub-activating enzyme known as the E1 component. The Ub chain is then conjugated to the Ub-conjugating enzyme (E2) to generate an intermediate Ub-E2 complex. The Ub-ligase (E3) then catalyzes the transfer of Ub from E2 to the appropriate protein substrate. UBE2A (Ubiquitin-conjugating enzyme E2 A) and UBE2B (Ubiquitin-conjugating enzyme E2 B) are both Ub-conjugating enzymes that are essential to postreplication repair of UV-damaged DNA. UBE2A and UBE2B are both nuclear and cell membrane proteins that have been found to interact with Rad18.

Gen-ID: 7319